Category: Genetic Disorders

Voxelotor, sold under the brand name Oxbryta, is a medication used for the treatment of sickle cell disease.[1][2][3][4][5] Developed by Global Blood Therapeutics, voxelotor is the first hemoglobin oxygen-affinity modulator.[6] Voxelotor has been shown to have disease-modifying potential by increasing hemoglobin levels and decreasing hemolysis indicators in sickle cell patients.[7] ... [wikipedia]

Related Brands

Drugs with the same active ingredients